New LTIP & Grant of Options
Surgical Innovations Group plc has established a new Long Term Incentive Plan (2025 LTIP) and granted nil cost options over 16,086,955 ordinary shares to executive directors and employees, including the CEO and CFO, with awards subject to revenue, EBIT, and total shareholder return performance over three years ending November 26, 2028.
Select text to share a quote on X · sign in to keep highlights & notes in your SUN notes
Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces the establishment of a new Long Term Incentive Plan ("2025 LTIP") for certain executive directors and employees in order to incentivise them in a manner that aligns with the interests of the Company's shareholders.
New LTIP
Under the terms of the 2025 LTIP, the Company has awarded nil cost share options (the "Options") over a total of 16,086,955 ordinary shares of 1 pence each in the Company ("Ordinary Shares") including to certain persons discharging managerial responsibilities ("PDMRs") as set out below.
The Options may be exercised at nil cost and are subject to performance criteria relating to revenue growth, EBIT growth and total shareholder returns alongside continuous employment with the Company for a period of three years ending on 26th November 2028.
The following PDMRs have been awarded Options:
| PDMRs | Role | No. of Options awarded | Total Options held post award |
|---|---|---|---|
| David Marsh | Chief Executive Officer | 9,130,434 | 9,130,434 |
| Brent Greetham | Chief Financial Officer | 6,956,521 | 6,956,521 |
In developing the 2025 LTIP and determining the award of Options, the Remuneration Committee engaged in consultation with the Company's largest shareholder.
| a) | Name | Surgical Innovations Group plc |
| b) | LEI | 2138004GHGUH3HUZE156 |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1p GB0004016704 |
| b) | Nature of the transactions | Grant of options |
| c) | Price(s) and volume(s) | Price(s) Volume(s) 1. nil 2. nil 1. 9,130,434 2. 6,956,521 |
| d) | Aggregated information - Aggregated volume - Price | N/A N/A |
| e) | Date of the transaction | 27 November 2025 |
| f) | Place of the transaction | Outside a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.